These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19390224)

  • 41. Evaluation of association of DRD2 TaqIA and -141C InsDel polymorphisms with food intake and anthropometric data in children at the first stages of development.
    Feistauer V; Vitolo MR; Campagnolo PDB; Mattevi VS; Almeida S
    Genet Mol Biol; 2018 Jul/Sept.; 41(3):562-569. PubMed ID: 30044466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.
    Stöber G; Jatzke S; Heils A; Jungkunz G; Knapp M; Mössner R; Riederer P; Lesch KP
    J Neural Transm (Vienna); 1998; 105(1):101-9. PubMed ID: 9588764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo.
    Hirvonen MM; Lumme V; Hirvonen J; Pesonen U; Någren K; Vahlberg T; Scheinin H; Hietala J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):630-6. PubMed ID: 19285111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between the DRD2-141C Insertion/Deletion polymorphism and schizophrenia.
    Cordeiro Q; Siqueira-Roberto J; Zung S; Vallada H
    Arq Neuropsiquiatr; 2009 Jun; 67(2A):191-4. PubMed ID: 19547807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
    Tung MC; Wen YC; Wang SS; Lin YW; Liu YC; Yang SF; Chien MH
    Int J Med Sci; 2018; 15(11):1187-1193. PubMed ID: 30123056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis.
    Yuan A; Su L; Yu S; Li C; Yu T; Sun J
    PLoS One; 2015; 10(6):e0131060. PubMed ID: 26110876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The ANKK1/DRD2 gene TaqIA polymorphism (rs1800497) is associated with the severity of extrapyramidal side effects of haloperidol treatment in CYP2D6 extensive metabolizers with schizophrenia spectrum disorders.
    Kibitov AA; Kiryanova EM; Salnikova LI; Bure IV; Shmukler AB; Kibitov AO
    Drug Metab Pers Ther; 2023 Jun; 38(2):133-142. PubMed ID: 36437548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.
    Styn MA; Nukui T; Romkes M; Perkins K; Land SR; Weissfeld JL
    Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):254-61. PubMed ID: 18563706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.
    Xing Q; Qian X; Li H; Wong S; Wu S; Feng G; Duan S; Xu M; Gao R; Qin W; Gao J; Meng J; He L
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):631-7. PubMed ID: 17105675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome.
    Mihara K; Kondo T; Suzuki A; Yasui-Furukori N; Ono S; Sano A; Koshiro K; Otani K; Kaneko S
    Am J Med Genet B Neuropsychiatr Genet; 2003 Feb; 117B(1):57-60. PubMed ID: 12555236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic polymorphisms of the promoter region of dopamine D2 receptor and dopamine transporter genes and alcoholism among four aboriginal groups and Han Chinese in Taiwan.
    Chen WJ; Chen CH; Huang J; Hsu YP; Seow SV; Chen CC; Cheng AT
    Psychiatr Genet; 2001 Dec; 11(4):187-95. PubMed ID: 11807408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
    Wu S; Xing Q; Gao R; Li X; Gu N; Feng G; He L
    Neurosci Lett; 2005 Mar; 376(1):1-4. PubMed ID: 15694263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine.
    Aklillu E; Kalow W; Endrenyi L; Harper P; Miura J; Ozdemir V
    Pharmacogenet Genomics; 2007 Nov; 17(11):989-93. PubMed ID: 18075468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
    Calarge CA; Ellingrod VL; Acion L; Miller DD; Moline J; Tansey MJ; Schlechte JA
    Pharmacogenet Genomics; 2009 May; 19(5):373-82. PubMed ID: 19339912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between dopamine receptor D2 Taq IA gene polymorphism and persistent postural-perceptual dizziness.
    Cui L; Yan Z; Gong L; Tang J; Kong M; Sun F; Yu Q; Liang H; Chen C
    J Vestib Res; 2019; 29(2-3):131-136. PubMed ID: 31356223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism.
    Parsian A; Cloninger CR; Zhang ZH
    Am J Med Genet; 2000 Jun; 96(3):407-11. PubMed ID: 10898923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population.
    Monakhov M; Golimbet V; Abramova L; Kaleda V; Karpov V
    Schizophr Res; 2008 Mar; 100(1-3):302-7. PubMed ID: 18255274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between a promoter dopamine D2 receptor gene variant and the personality trait detachment.
    Jönsson EG; Cichon S; Gustavsson JP; Grünhage F; Forslund K; Mattila-Evenden M; Rylander G; Asberg M; Farde L; Propping P; Nöthen MM
    Biol Psychiatry; 2003 Apr; 53(7):577-84. PubMed ID: 12679235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a high-throughput method for screening the dopamine D2 (DRD2) receptor gene polymorphisms based on the LightCycler system.
    Stefan P; Moritz E; Alexander W; Weber M; Norbert D; Annette W; Thomas F; Andreas P
    Clin Lab; 2009; 55(9-10):353-8. PubMed ID: 20099571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia.
    Jönsson EG; Nöthen MM; Neidt H; Forslund K; Rylander G; Mattila-Evenden M; Asberg M; Propping P; Sedvall GC
    Schizophr Res; 1999 Nov; 40(1):31-6. PubMed ID: 10541004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.